Analyst Ratings published Tuesday April 2nd 2024

4/2/24	Resumed	Buy	X
ALDX Aldeyra Therapeutics H.C. Wainwright
$10
4/2/24	Upgrades	Mkt Perform Mkt Outperform	X
ANTX AN2 Therapeutics JMP Securities
$6
4/2/24	Upgrades	Eq Weight Overweight	X
ARRY Array Tech Barclays
$15 $18
4/2/24	Downgrades	Outperform Mkt Perform	X
BCE BCE Inc BMO Capital Markets
4/2/24	Upgrades	Sell Neutral	X
BF-B Brown-Forman Citigroup
$52
4/2/24	Downgrades	Overweight Neutral	X
BMEA Biomea Fusion JP Morgan
$51 $14
4/2/24	Downgrades	Buy Neutral	X
BX Blackstone UBS
$140 $135
4/2/24	Downgrades	Neutral Underperform	X
CCS Century Communities Wedbush
$92 $82
4/2/24	Downgrades	Buy Neutral	X
CLX Clorox Citigroup
$170 $165
4/2/24	Downgrades	Neutral Underperform	X
DHI D.R. Horton Wedbush
$130
4/2/24	Upgrades	Neutral Buy	X
EL Estee Lauder Citigroup
$160 $175
4/2/24	Upgrades	Underweight Eq Weight	X
ETN Eaton Barclays
$250 $300
4/2/24	Downgrades	Neutral Underperform	X
FIGS FIGS, Inc. BofA Securities
$8.50 $4.50
4/2/24	Reiterated	Overweight	X
HQY HealthEquity JP Morgan
$86 $108
4/2/24	Downgrades	Buy Neutral	X
HUM Humana BofA Securities
$470 $342
4/2/24	Downgrades	Neutral Underperform	X
LEN Lennar Wedbush
$144
4/2/24	Downgrades	Neutral Underperform	X
LGIH LGI Homes Wedbush
$88 $74
4/2/24	Upgrades	Eq Weight Overweight	X
MCO Moody’s Barclays
$375 $450
4/2/24	Upgrades	Hold Buy	X
MKC McCormick Argus
4/2/24	Initiated	Neutral	X
MLTX MoonLake Immunotherapeutics Goldman
$62
4/2/24	Initiated	Buy	X
MLYS Mineralys Therapeutics Goldman
$30
4/2/24	Initiated	Buy	X
MQ Marqeta Monness Crespi & Hardt
$7.50
4/2/24	Downgrades	Neutral Underperform	X
MTH Meritage Wedbush
$155 $148
4/2/24	Downgrades	Buy Neutral	X
MVST Microvast Janney
4/2/24	Upgrades	Underperform Outperform	X
NGG National Grid Exane BNP Paribas
4/2/24	Downgrades	Eq Weight Underweight	X
NIO NIO Barclays
$4
4/2/24	Initiated	Buy	X
NLY Annaly Capital Mgmt Compass Point
$22
4/2/24	Downgrades	Overweight Eq Weight	X
NXT Nextracker Barclays
$55 $63
4/2/24	Initiated	Buy	X
OLMA Olema Pharmaceuticals Goldman
$24
4/2/24	Reiterated	Outperform	X
OMC Omnicom Macquarie
$100 $110
4/2/24	Downgrades	Buy Neutral	X
OSPN OneSpan Sidoti
$12
4/2/24	Initiated	Hold	X
OTIS Otis Worldwide Melius
4/2/24	Upgrades	Neutral Buy	X
OWL Blue Owl Capital UBS
$18 $22
4/2/24	Initiated	Neutral	X
RCKT Rocket Pharmaceuticals Goldman
$39
4/2/24	Downgrades	Outperform Mkt Perform	X
UGP Ultrapar Participacoes Itau BBA
4/2/24	Downgrades	Buy Underperform	X
WOOF Petco Health and Wellness BofA Securities
$5 $1.50
4/2/24	Initiated	Equal Weight	X
ZBRA Zebra Tech Barclays
$292
4/2/24	Reiterated	Buy	X
ZVRA Zevra Therapeutics Maxim Group
$12 $18